Actio Biosciences (San Diego, US) is developing a portfolio of drugs to modulate the activity of proteins responsible for rare diseases with the potential to translate these findings into common diseases – actiobio.com
Location: United States, California, San Diego
Investors 1
| Date | Name | Website |
| - | Droia Onco... | droiaventu... |
Persons 3
| Date | First Name | Last Name | Title | Location | |||
| - | David B. | Goldstein | Chief Exec... | linkedin.c... | - | d*********... | - |
| - | David | Breckenrid... | Chief Busi... | linkedin.c... | - | D*********... | - |
| - | Sunil | Sahdeo | Senior Dir... | linkedin.c... | - | s*********... | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 13.09.2023 | Actio Biosciences Announces $55 Million Series A Financing t... | - | canaan.com... |
| 12.09.2023 | Actio Biosciences closes $55M to new therapeutics for rare a... | - | connect.or... |
| - | 9 top West Coast biotechs that VCs say are poised to take of... | Tayfun Coskun/Anadolu Agency/Getty Images This story is available exclusively to Insider subscribers... | businessin... |
| - | Meet the 23 biotech startups that are set to take off in the... | Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and s... | businessin... |